Status:
UNKNOWN
Study of Demarcation Line Depth in Transepithelial Versus Epithelium-off Accelerated Cross-linking (AXL) in Keratocouns
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Progressive Keratoconus
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
To assess depth of demarcation line in transepithelial versus epithelium-off accelerated cross-linking in keratoconus patients
Detailed Description
Anterior segment optical coherence tomography "OCT" will be performed to evaluate the corneal stroma for the presence of demarcation line 1 month postoperatively by an independent observer unware of p...
Eligibility Criteria
Inclusion
- progressive keratoconus stage 1-2
Exclusion
- any concomitant ocular disease
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04045626
Start Date
August 1 2019
End Date
March 1 2020
Last Update
August 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr Al Ainy teaching hospital
Cairo, Egypt